Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells

Atomoxetine (ATX) is a non-stimulant drug used in the treatment of attention-deficit/hyperactivity disorder (ADHD) and is a selective norepinephrine reuptake inhibitor. It has been shown that ATX has additional effects beyond the inhibition of norepinephrine reuptake, affecting several signal transd...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona, Juan Carlos, Carreón-Trujillo, Sonia, González-Pérez, Raquel, Gómez-Bautista, Denise, Vázquez-González, Daniela, Salazar-García, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737196/
https://www.ncbi.nlm.nih.gov/pubmed/31506604
http://dx.doi.org/10.1038/s41598-019-49609-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737196/
https://www.ncbi.nlm.nih.gov/pubmed/31506604
http://dx.doi.org/10.1038/s41598-019-49609-9

Ejemplares similares